A69: Exploring Stakeholder Engagement in Times of Controversy
Journal of Business Ethics Education · 2025 · 22 · 163-174
DOI: 10.5840/jbee20252210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Business Ethics Education, 2025. Verfasst von Charline Collard und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This case study examines the controversial A69 motorway project—a 53 km toll road between Castres and Toulouse, in France—designed to boost regional connectivity and economic growth. Despite being declared a public utility, the project faced escalating resistance from local officials, environmental groups, and civil society, who criticized its environmental impact, lack of transparency, and questionable public interest. Allegations of opaque financing and lobbying by key stakeholders intensified scrutiny. Civil resistance included protests, hunger strikes, and legal actions. In 2025 a court of law ruled the project illegal due to the absence of an overriding public need, halting construction. This ongoing case, now under appeal, highlights broader tensions between economic development, environmental sustainability, and democratic accountability in large infrastructure projects. It offers students the possibility of exploring CSR from a broader perspective, allowing them to critically analyze a real-world situation.
Zitieren
APA
Collard, C., Pündrich, A. P., & Yalenios, J. (2025). A69: Exploring Stakeholder Engagement in Times of Controversy. Journal of Business Ethics Education, 22, 163-174. https://doi.org/10.5840/jbee20252210
Vancouver
Collard C, Pündrich AP, Yalenios J. A69: Exploring Stakeholder Engagement in Times of Controversy. Journal of Business Ethics Education. 2025;22:163-174. doi:10.5840/jbee20252210
BibTeX
@article{Collard2025,
author = {Collard, Charline and Pündrich, Aline P. and Yalenios, Jocelyne},
title = {A69: Exploring Stakeholder Engagement in Times of Controversy},
journal = {Journal of Business Ethics Education},
year = {2025},
volume = {22},
pages = {163--174},
doi = {10.5840/jbee20252210}
}
EUVIMED